ABOUT THE PRODUCT
A novel genetically targeted therapy for locally advanced metastatic p53 wild-type tumors, currently in Phase 1/2a clinical trials.
Information is owner-confirmed
Last updated 2 days ago
Price range
Other products/services from Lamassu BioTech
RABI-767
Biotechnology
N/A
Lamassu BioTech
United States (US)